skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,979,690  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
Material Type:
Article
Add to My Research

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications

Journal of Alzheimer's disease, 2020-01, Vol.77 (2), p.459 [Peer Reviewed Journal]

EISSN: 1875-8908 ;DOI: 10.3233/jad-200831 ;PMID: 32925078

Digital Resources/Online E-Resources

2
The Unequal Pandemic: COVID-19 and Health Inequalities
Material Type:
Book
Add to My Research

The Unequal Pandemic: COVID-19 and Health Inequalities

Bristol University Press ;Bristol University Press 2021 ;ISBN: 9781447361237 ;ISBN: 1447361237 ;ISBN: 1447361253 ;ISBN: 9781447361251 ;EISBN: 1447361253 ;EISBN: 9781447361244 ;EISBN: 1447361245 ;EISBN: 9781447361251 ;DOI: 10.46692/9781447361251 ;OCLC: 1257077799

Full text available

3
The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine
Material Type:
Book
Add to My Research

The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine

2021 ;ISBN: 9780309268370 ;ISBN: 0309268370 ;EISBN: 0309268613 ;EISBN: 9780309268615 ;EISBN: 0309269067 ;EISBN: 9780309269063 ;DOI: 10.17226/26061 ;OCLC: 1256238530

Digital Resources/Online E-Resources

4
Coronavirus Politics : The Comparative Politics and Policy of COVID-19
Material Type:
Book
Add to My Research

Coronavirus Politics : The Comparative Politics and Policy of COVID-19

https://creativecommons.org/licenses/by-nc/4.0/legalcode ;Ann Arbor, Michigan : University of Michigan Press, ©2021 ;ISBN: 0472902466 ;ISBN: 9780472902460 ;ISBN: 9780472038626 ;ISBN: 0472038621 ;EISBN: 0472902466 ;EISBN: 9780472902460 ;DOI: 10.3998/mpub.11927713 ;LCCallNum: RA644.C67

Full text available

5
COVID-19 in the Environment: Impact, Concerns, and Management of Coronavirus
Material Type:
Book
Add to My Research

COVID-19 in the Environment: Impact, Concerns, and Management of Coronavirus

ISBN: 0323902723 ;ISBN: 9780323902724 ;EISBN: 9780323902731 ;EISBN: 0323902731 ;DOI: 10.1016/C2020-0-03518-8 ;OCLC: 1269096029

Full text available

6
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990

Full text available

7
COVID-19 diagnosis -A review of current methods
Material Type:
Article
Add to My Research

COVID-19 diagnosis -A review of current methods

Biosensors & bioelectronics, 2021-01, Vol.172, p.112752 [Peer Reviewed Journal]

Copyright © 2020 Elsevier B.V. All rights reserved. ;EISSN: 1873-4235 ;DOI: 10.1016/j.bios.2020.112752 ;PMID: 33126180

Digital Resources/Online E-Resources

8
MRI study charts organ damage months after COVID-19
Material Type:
Article
Add to My Research

MRI study charts organ damage months after COVID-19

Science (American Association for the Advancement of Science), 2023-09, Vol.381 (6665), p.1385-1385 [Peer Reviewed Journal]

Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.adl0645

Digital Resources/Online E-Resources

9
Correction: Evolution and consequences of individual responses during the COVID-19 outbreak
Material Type:
Article
Add to My Research

Correction: Evolution and consequences of individual responses during the COVID-19 outbreak

PloS one, 2023-10, Vol.18 (10), p.e0292775-e0292775 [Peer Reviewed Journal]

COPYRIGHT 2023 Public Library of Science ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Abbas et al 2023 Abbas et al ;2023 Abbas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0292775

Full text available

10
WHO's new chief scientist wants to look to 'tomorrow'
Material Type:
Article
Add to My Research

WHO's new chief scientist wants to look to 'tomorrow'

Science (American Association for the Advancement of Science), 2023-06, Vol.380 (6652), p.1310-1311 [Peer Reviewed Journal]

Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.adj4499 ;PMID: 37384688

Digital Resources/Online E-Resources

11
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Material Type:
Article
Add to My Research

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432

Digital Resources/Online E-Resources

12
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Material Type:
Article
Add to My Research

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

JAMA internal medicine, 2021-05, Vol.181 (5), p.672 [Peer Reviewed Journal]

EISSN: 2168-6114 ;DOI: 10.1001/jamainternmed.2021.0366 ;PMID: 33625463

Digital Resources/Online E-Resources

13
The unrecovered
Material Type:
Article
Add to My Research

The unrecovered

Science (American Association for the Advancement of Science), 2023-01, Vol.379 (6628), p.145-145 [Peer Reviewed Journal]

Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.adf7568

Digital Resources/Online E-Resources

14
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

15
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Material Type:
Article
Add to My Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923

Full text available

16
Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated
Material Type:
Article
Add to My Research

Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated

PloS one, 2022-07, Vol.17 (7), p.e0271154-e0271154 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The PLOS ONE Staff 2022 The PLOS ONE Staff ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0271154 ;PMID: 35789344

Full text available

17
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Material Type:
Article
Add to My Research

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

Nature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2022 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00662-4 ;PMID: 34876702

Full text available

18
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Nature medicine, 2021-11, Vol.27 (11), p.2032-2040 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01540-1 ;PMID: 34588689

Full text available

19
Patients Readmitted with COVID-19 Less Likely to Die on Readmission
Material Type:
Conference Proceeding
Add to My Research

Patients Readmitted with COVID-19 Less Likely to Die on Readmission

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4627

Full text available

20
Covid-19 and Tdap vaccination among pregnant persons in Ontario, Canada: A population-based retrospective cohort study
Material Type:
Conference Proceeding
Add to My Research

Covid-19 and Tdap vaccination among pregnant persons in Ontario, Canada: A population-based retrospective cohort study

Annals of family medicine, 2023, Vol.21 (Suppl 3) [Peer Reviewed Journal]

2023 Annals of Family Medicine, Inc. 2023 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.22.s1.4869

Full text available

Results 1 - 20 of 6,979,690  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1999  (16)
  2. 1999 To 2005  (14)
  3. 2006 To 2012  (42)
  4. 2013 To 2019  (492)
  5. After 2019  (6,979,615)
  6. More options open sub menu

Resource Type 

  1. Newsletter Articles  (4,682,869)
  2. Newspaper Articles  (1,132,616)
  3. Articles  (733,227)
  4. Web Resources  (183,639)
  5. magazinearticle  (160,226)
  6. Text Resources  (35,992)
  7. Reports  (31,209)
  8. Thesises (postgraduate)  (4,172)
  9. Reviews  (3,502)
  10. Books  (3,495)
  11. Book Chapters  (2,408)
  12. Conference Proceedings  (2,346)
  13. Datasets  (1,573)
  14. Images  (1,139)
  15. Videos  (638)
  16. Audio  (197)
  17. Market Research  (172)
  18. Archival Material / Manuscripts  (122)
  19. Standards  (87)
  20. References  (29)
  21. More options open sub menu

Subject 

  1. Covid-19  (6,416,068)
  2. Coronaviruses  (4,790,262)
  3. Pandemics  (2,597,246)
  4. Covid-19 Vaccines  (713,228)
  5. Earnings Per Share  (536,743)
  6. Stockholders  (475,463)
  7. Disease Transmission  (410,184)
  8. Immunization  (376,555)
  9. Vaccines  (341,881)
  10. Science & Technology  (328,018)
  11. Corporate Profits  (302,601)
  12. Dividends  (298,236)
  13. Life Sciences & Biomedicine  (291,129)
  14. Severe Acute Respiratory Syndrome Coronavirus 2  (290,566)
  15. Public Health  (273,004)
  16. Investments  (261,033)
  17. Form 10-K  (244,097)
  18. Stock Exchanges  (240,340)
  19. Employees  (221,202)
  20. Corporate Profiles  (219,398)
  21. More options open sub menu

Language 

  1. English  (6,740,313)
  2. Spanish  (169,854)
  3. French  (50,575)
  4. Portuguese  (29,364)
  5. Japanese  (21,319)
  6. German  (10,913)
  7. Russian  (3,273)
  8. Arabic  (2,028)
  9. Chinese  (1,987)
  10. Turkish  (1,929)
  11. Urdu  (1,430)
  12. Indonesian  (1,348)
  13. Norwegian  (961)
  14. Catalan  (851)
  15. Finnish  (824)
  16. Persian  (782)
  17. Italian  (748)
  18. Polish  (628)
  19. Czech  (583)
  20. Korean  (499)
  21. More options open sub menu

Searching Remote Databases, Please Wait